NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,732 | +0.9% | 17 | 0.0% | 0.00% | – |
| Q2 2023 | $1,716 | +9.7% | 17 | 0.0% | 0.00% | – |
| Q1 2023 | $1,564 | -94.6% | 17 | -94.6% | 0.00% | -100.0% |
| Q4 2022 | $28,758 | +19.8% | 317 | 0.0% | 0.01% | +12.5% |
| Q3 2022 | $24,000 | -22.6% | 317 | -13.2% | 0.01% | -11.1% |
| Q2 2022 | $31,000 | -3.1% | 365 | 0.0% | 0.01% | +28.6% |
| Q1 2022 | $32,000 | +23.1% | 365 | +21.7% | 0.01% | +40.0% |
| Q4 2021 | $26,000 | +4.0% | 300 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $25,000 | -7.4% | 300 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $27,000 | +3.8% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $26,000 | -7.1% | 300 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $28,000 | +7.7% | 300 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $26,000 | -44.7% | 300 | -44.5% | 0.01% | -53.3% |
| Q2 2020 | $47,000 | +88.0% | 541 | +80.3% | 0.02% | +50.0% |
| Q1 2020 | $25,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |